Xconomy | Boston - Business + Technology in the Exponential Economy

Related Posts

pharma, deals, Celldex

Celldex Nabs $10M Milestone

Rebecca Zacks 10/2/08

Needham, MA-based Celldex Therapeutics (NASDAQ: CLDX) said it has received a $10 million milestone payment triggered by the U.S. launch of the oral rotavirus vaccine Rotarix, which is marketed by GlaxoSmithKline (NYSE: GSK). Celldex was formed through the recent merger of Avant Immunotherapeutics of Needham and Phillipsburg, NJ-based Celldex Therapeutics.

Comments | Permalink | Share this post Share | E-mail E-mail

Add Your Thoughts



You will have 10 minutes to edit your post after you press publish.

Comments may be edited for clarity and length, rejected, or deleted. By clicking "Publish," you are agreeing to these Terms and Conditions.

    
Xconomy network map
Visit a city in our network or go to
Xconomy National
for network hightlights
Seattle Boston San Diego

Most Popular Stories

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.

© 2007-2008 Xconomy. All rights reserved. Site designed by Matthew Bouchard, produced by Andrew Koyfman, and powered by WordPress.